Inverse relationship between numbers of 5-HT transporter binding sites and life history of aggression and intermittent explosive disorder

Journal of Psychiatric Research

Volumn 44, Issue 3, 2010, Pages 137-142

  Coccaro, Emil F ^a   Lee, Royce ^a   Kavoussi, Richard J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

5 HT transporter; Aggression; IED

Indexed keywords

PAROXETINE; SEROTONIN TRANSPORTER;

ADULT; AGGRESSION; ARTICLE; BINDING SITE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMAN; IMPULSIVENESS; INTERMITTENT EXPLOSIVE DISORDER; LIFE HISTORY; MAJOR CLINICAL STUDY; MALE; PATIENT IDENTIFICATION; PRIORITY JOURNAL; RECEPTOR BINDING; THROMBOCYTE;

EID: 77649338460     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2009.07.004     Document Type: Article

References (55)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Association Press, Washington, DC. 4th ed.
2. Anderson G.M., Gutknecht L., Cohen D.J., Brailly-Tabard S., Cohen J.H., Ferrari P., et al. Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia. Molecular Psychiatry 2002, 7:831-836.
3. Birmaher B., Stanley M., Greenhill L., Twomey J., Gavrilescu A., Rabinovich H. Platelet imipramine binding in children and adolescents with impulsive behavior. Journal of American Academy of Child and Adolescent Psychiatry 1990, 29:914-918.
4. Buss A.H., Durkee A. An inventory for assessing different kinds of hostility. Journal of Consulting Psychology 1957, 21:343-349.
5. Coccaro E.F. Intermittent explosive disorder. Aggression: Psychiatric Assessment and Treatment 2003, 149:199.
6. Coccaro E.F., Berman M.E., Kavoussi R.J. Assessment of life history of aggression: development and psychometric characteristics. Psychiatry Research 1997, 73:147-157.
7. Coccaro E.F., Kavoussi R.J., Berman M.E., Lish J.D. Intermittent explosive disorder-revised: development, reliability, and validity of research criteria. Comprehensive Psychiatry 1998, 39:368-376.
8. Coccaro E.F., Kavoussi R.J., Sheline Y.I., Lish J.D., Csernansky J.G. Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelet. Archives of General Psychiatry 1996, 53:531-536.
9. Coccaro E.F., Lee R.J., Kavoussi R.J. A double-blind, randomized, placebo-controlled trial of fluoxetine in patients with intermittent explosive disorder. Journal of Clinical Psychiatry 2009, 70:653-662.
10. Coccaro E.F., McCloskey M.S., Fitzgerald D.A., Phan K.L. Amygdala and orbitofrontal reactivity to social threat in individuals with impulsive aggression. Biological Psychiatry 2007, 62:168-178.
11. Coccaro E.F., Schmidt C.A., Samuels J.F., Nestadt G. Lifetime and 1-month prevalence rates of intermittent explosive disorder in a community sample. Journal of Clinical Psychiatry 2004, 65:820-824.
12. Coccaro E.F., Siever L.J., Klar H.M., Maurer G., Cochrane K., Cooper T.B., et al. Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Archives of General Psychiatry 1989, 46:587-599.
13. Coccaro E.F., Siever L.J. Pathophysiology and Treatment of Aggression. Psychopharmacology: The Fifth Generation of Progress 2002, 1709:1709-1723.
14. Eysenck H.J., Eysenck S.B.G. Manual of the Eysenck personality questionnaire (junior and adult) 1975, Hodder and Stoughton, London.
15. First MB S.R., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID) 1997, Psychiatric Institute, Biometrics Research, New York.
16. Frankle W.G., Lombardo I., New A.S., Goodman M., Talbot P.S., Huang Y., et al. Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN 5652. American Journal of Psychiatry 2005, 162:915-923.
17. Hanna G.L., Himle J.A., Curtis G.C., Koram D.Q., Veenstra-VanderWeele J., Leventhal B.L., et al. Serotonin transporter and seasonal variation in blood serotonin in families with obsessive-compulsive disorder. Neuropsychopharmacology 1998, 18:102-111.
18. Heinz A., Jones D.W., Mazzanti C., Goldman D., Ragan P., Hommer D., et al. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biological Psychiatry 2000, 47:643-649.
19. Javors M.A., Seneviratne C., Roache J.D., Ait-Daoud N., Bergeson S.E., Walss-Bass M.C., et al. Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics. Progress in Neuropsychopharmacology and Biological Psychiatry 2005, 29:7-13.
20. Kessler R.C., Coccaro E.F., Fava M., Jaeger S., Jin R., Walters E. The prevalence and correlates of DSM-IV intermittent explosive disorder in the National Comorbidity Survey Replication. Archives of General Psychiatry 2006, 63:669-678.
21. Klein D.N., Ouimette P.C., Kelly H.S., Ferro T., Riso L.P. Test-retest reliability of team consensus best-estimate diagnoses of axis I and II disorders in a family study. American Journal of Psychiatry 1994, 151:1043-1047.
22. Kosten T.A., Rounsaville B.J. Sensitivity of psychiatric diagnosis based on the best estimate procedure. American Journal of Psychiatry 1992, 149:1225-1227.
23. Leckman J.F., Sholomskas D., Thompson W.D., Belanger A., Weissman M.M. Best estimate of lifetime psychiatric diagnosis: a methodological study. Archives of General Psychiatry 1982, 39:879-883.
24. Lesch K.-P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., et al. Association of anxiety related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274:1527-1531.
25. Lesch K.P., Wolozin B.L., Murphy D.L., Reiderer P. Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. Journal of Neurochemistry 1993, 60:2319-2322.
26. Little K.Y., McLaughlin D.P., Zhang L., Livermore C.S., Dalack G.W., McFinton P.R., et al. Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. American Journal of Psychiatry 1998, 155:207-213.
27. Little K.Y., Zhang L., Cook E. Fluoxetine-induced alterations in human platelet serotonin transporter expression: serotonin transporter polymorphism effects. Journal of Psychiatry and Neuroscience 2006, 31:333-339.
28. Maguire K., Cheung P., Crowley K., Norman T., Schweitzer I., Burrows G. Aggressive behaviour and platelet 3H-paroxetine binding in schizophrenia. Schizophrenia Research 1997, 23:61-67.
29. Marazziti D., Conti L., Pfanner C., Presta S., Rossi A., Gemignani A., et al. No correlation between aggression and platelet (3)H-paroxetine binding in obsessive-compulsive disorder patients. Neuropsychobiology 2001, 43:117-122.
30. Marazziti D., Rotondo A., Presta S., Panioli-Guadagnucci M., Palego L., Conti L. Role of serotonin in human aggressive behavior. Aggressive Behavior 1993, 9:347-353.
31. McCloskey M.S., Lee R., Berman M.E., Noblett K.L., Coccaro E.F. The relationship between impulsive verbal aggression and intermittent explosive disorder. Aggress Behaviour 2008, 34:51-60.
32. McCloskey M.S., Noblett K.L., Deffenbacher J.L., Gollan J.K., Coccaro E.F. Cognitive-behavioral therapy for intermittent explosive disorder: a pilot randomized clinical trial. Journal of Consulting and Clinical Psychology 2008, 76:876-886.
33. Mellerup E., Bennike B., Bolwig T., Dam H., Hasholt L., Jorgensen M.B., et al. Platelet serotonin transporters and the transporter gene in control subjects unipolar patients and bipolar patients. Acta Psychiatrica Scandinavica 2001, 103:229-233.
34. Modai I., Gibel A., Rauchverger B., Ritsner M., Klein E., Ben-Shachar D. Paroxetine binding in aggressive schizophrenic patients. Psychiatry Research 2000, 94:77-81.
35. Murphy D, Mellow A, Sunderl T, Aulahk C, Lawlor B, Zohar J. Strategies for assessing serotonin in humans. In: Coccaro EF, Murphy DL, editors. Serotonin in Major Psychiatric Disorders, 1990.
36. Naylor L., Dean B., Pereira A., Mackinnon A., Kouzmenko A., Copolov D. No association between the serotonin transporter-linked promoter region polymorphism and either schizophrenia or density of the serotonin transporter in human hippocampus. Molecular Medicine 1998, 4:671-674.
37. New A.S., Hazlett E.A., Buchsbaum M.S., Goodman M., Reynolds D., Mitropoulou V., et al. Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression. Archives of General Psychiatry 2002, 59:621-629.
38. Oades R.D., Slusarek M., Velling S., Bondy B. Serotonin platelet-transporter measures in childhood attention-deficit/hyperactivity disorder (ADHD): clinical versus experimental measures of impulsivity. World Journal of Biological Psychiatry 2002, 3:96-100.
39. Patkar A.A., Berrettini W.H., Mannelli P., Gopalakrishnan R., Hoehe M.R., Bilal L., et al. Relationship between serotonin transporter gene polymorphisms and platelet serotonin transporter sites among African-American cocaine-dependent individuals and healthy volunteers. Psychiatric Genetics 2004, 14:25-32.
40. Patkar A.A., Gottheil E., Berrettini W.H., Hill K.P., Thornton C.C., Weinstein S.P. Relationship between platelet serotonin uptake sites and measures of impulsivity, aggression, and craving among African-American cocaine abusers. American Journal of Addictions 2003, 12:432-447.
41. Patkar A.A., Berrettini W.H., Lundy A., Murray H.W., Hill K.P., Vergeare M.J., et al. Seasonal variations in the binding of 3[H]paroxetine serotonin transporter sites in African-American cocaine-dependent patients and healthy volunteers. Human Psychopharmacology 2003, 18:103-111.
42. Patton J.H., Stanford M.S., Barratt E.S. Factor structure of the Barratt impulsiveness scale. Journal of Clinical Psychology 1995, 51:768-774.
43. Pfohl B., Blum N., Zimmerman M. Structured interview for the DSM-III-R personality disorders 1989, University of Iowa Press, Iowa City.
44. Pfohl B., Blum N., Zimmerman M. University of Iowa. Dept. of, P. Structured interview for DSM-IV personality: SIDP-IV 1997, American Psychiatric Press, Washington, DC.
45. Ramamoorthy S., Bauman A.L., Moore K.R., Han H., Yang-Feng T., Chang A.S., et al. Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proceedings of the National Academy of Sciences USA 1993, 90:2542-2546.
46. Sarne Y., Mandel J., Goncalves M.H., Brook S., Gafni M., Elizur A. Imipramine binding to blood platelets and aggressive behavior in offenders, schizophrenics and normal volunteers. Neuropsychobiology 1995, 31:120-124.
47. Siever L.J., Buchsbaum M.S., New A.S., Spiegel-Cohen J., Wei T., Hazlett E.A., et al. D, L-fenfluramine response in impulsive personality disorder assessed with [18F]fluorodeoxyglucose positron emission tomography. Neuropsychopharmacology 1999, 20:413-423.
48. Simeon D., Stanley B., Frances A., Mann J.J., Winchel R., Stanley M. Self-mutilation in personality disorders: psychological and biological correlates. American Journal of Psychiatry 1992, 149:221-226.
49. Spitzer R.L., Endicott J. Schedule for affective disorders and schizophrenia 1978, New York State Psychiatric Institute, New York.
50. Stoff D.M., Ieni J., Friedman E., Bridger W.H., Pollock L., Vitiello B. Platelet 3H-imipramine binding, serotonin uptake, and plasma alpha 1 acid glycoprotein in disruptive behavior disorders. Biological Psychiatry 1991, 29:494-498.
51. Stoff D.M., Pollock L., Vitiello B., Behar D., Bridger W.H. Reduction of (3H)-imipramine binding sites on platelets of conduct-disordered children. Neuropsychopharmacology 1987, 1:55-62.
52. Stoltenberg S.F., Twitchell G.R., Hanna G.L., Cook E.H., Fitzgerald H.E., Zucker R.A., et al. Serotonin transporter promoter polymorphism, peripheral indices of serotonin function, and personality measures in families with alcoholism. American Journal of Medical Genetics 2002, 114:230-234.
53. Tiihonen J., Kuikka J.T., Bergstrom K.A., Karhu J., Viinamaki H., Lehtonen J., et al. Single-photon emission tomography imaging of monoamine transporters in impulsive violent behaviour. European Journal of Nuclear Medicine 1997, 24:1253-1260.
54. Unis A.S., Cook E.H., Vincent J.G., Gjerde D.K., Perry B.D., Mason C., et al. Platelet serotonin measures in adolescents with conduct disorder. Biological Psychiatry 1997, 42:553-559.
55. Willeit M., Stastny J., Pirker W., Praschak-Rieder N., Neumeister A., Asenbaum S. No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism. Biological Psychiatry 2001, 50:8-12.